Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer


ACAR Ö., AYGÖR KABASAKAL E., ŞAHBAZLAR M., EKİNCİ F., ERDOĞAN A. P.

Turkish Journal of Clinics and Laboratory, cilt.1, sa.1861167, ss.1-8, 2026 (TRDizin)